NOVEN PHARMACEUTICALS, INC.

ACCUFIX

Pull-tabs sold as an integral component with a transdermal or transdermucosal patch to remove the release liners of said patches;

ACCUFIX

ACCURATE FIX;Pull-tabs which remove the protective release liner covering the sticky surface of a medicated or non-medicated transdermal drug delivery bandage or patch;

ACCUFIX

Pull-tabs sold as a component of a medicated transdermal or transmucosal patch which removes the protective release liner;Pull-tabs sold as a component of a non-medicated transdermal or transmucosal patch which removes the protective release liner;

ACCUPLY

ACCURATE PLY;Pull-tabs sold as an integral component with a transdermal or transmucosal patch to remove the release liners of said patches;

ADDEASE

Transdermal and transmucosal drug delivery patches for use in the treatment of attention deficit disorder and attention deficit hyperactivity disorder;ADD EASE;

ADDEVA

Transdermal and transmucosal drug delivery patches for use in the treatment of attention deficit disorder and attention deficit hyperactivity disorder;

ADDEVA

Transdermal and transmucosal drug delivery patches for use in the treatment of attention deficit disorder and attention deficit hyperactivity disorder;

ADDEX

Transdermal and transmucosal drug delivery patches for use in the treatment of attention deficit disorder and attention deficit hyperactivity disorder;

ADDJUST

Transdermal and transmucosal drug delivery patches for use in the treatment of attention deficit disorder and attention deficit hyperactivity disorder;ADD JUST;

ANDRODOT

Pharmaceutical preparations, namely, therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of hormonal or steroidal active agents;

ANDRODOT

Pharmaceutical preparations, namely therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of hormonal or steroidal active agents;AND RODOT;

APAXA

Transdermal and transmucousal drug delivery patches for use in the treatment of attention deficit disorder and attention deficit hyperactivity disorder;

APHNEVE

Pharmaceutical preparations, namely, contraceptives in the form of a transdermal patch;

APPLICAID

Pull tabs sold as an integral component of transdermal or transmucosal patches to remove the release liner of said patch;

APPLICAID

Pull tabs sold as an integral component with a transdermal or transmucosal patch to remove the release liner of said patches;

APPLICAID

Pull tabs sold as an integral component of transdermal or transmucosal patches to remove the release liner of said patch.;

APPLICAN

Pull-tabs sold as an integral component of a non-medicated transdermal or transmucosal patch which removes the protective release liner of said patche;

APPLICAN

Transdermal drug delivery patches sold with medication, namely pull-tabs that remove the release liner of said patches.;

APPLICON

Pull-tabs sold as an integral component with a transdermal or transdermucosal patch to remove the release liners of said patches;

APPLICON

Pull-tabs sold as a component of a non-medicated transdermal or transmucosal patch which removes the protective release liner;

APPLICON

Pull-tabs sold as a component of a medicated transdermal or transmucosal patch which removes the protective release liner;Pull-tabs sold as a component of a non-medicated transdermal or transmucosal patch which removes the protective release liner;

ATTEVA

Transdermal and transmucosal drug delivery patches for use in the treatment of attention deficit disorder and attention deficit hyperactivity disorder;

BITZEE

Pharmaceutical preparations, namely, contraceptives in the form of a transdermal patch;

COMBIDOT

Pharmaceutical preparations, namely, therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of hormonal or steroidal agents for the treatment of hormonal imbalances and deficiencies;

COMBIDOT

Pharmaceutical preparations, namely therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of a hormonal or steroidal active agent;

COMBIPATCH

pharmaceutical preparation for hormone therapy containing at least one estrogen and at least one progestogen;COMBINATION PATCH;

DENTIPATCH

oral patch for delivery of anesthetics and analgesics;DENTIST PATCH;

DENTIPATCH.COM

PROVIDING ON-LINE INFORMATION ABOUT DENTAL PRODUCTS VIA A GLOBAL COMPUTER NETWORK;DENTAL PATCH COM;

DENTIRINSE

mouthwash;

DOT

MANUFACTURE OF TRANSDERMAL PATCHES FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS TO ORDER AND/OR SPECIFICATION OF OTHERS;PHARMACEUTICAL PREPARATIONS DISPENSED BY PRESCRIPTION ONLY, NAMELY TRANSDERMAL ADHESIVE MATRIX PATCHES INTO WHICH A WIDE VARIETY OF BIOLOGICALLY ACTIVE AGENTS ARE PLACED FOR THE SYSTEMIC TREATMENT OF ALLERGIC, CARDIO-VASCULAR, INFECTIOUS, NEUROLOGICAL, INFLAMMATORY, IMMUNOLOGICAL, METABOLIC, VIRAL, MICROBIAL, OSTEOPATHIC, DIETARY, RESPIRATORY, PSYCHIATRIC, HORMONAL, DENTAL, DERMAL, MUSCULAR, AND EXCRETORY DISEASES, CONDITIONS, DEFICIENCIES AND DISORDERS;

DOT

MANUFACTURE OF TRANSDERMAL PATCHES FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS TO ORDER AND/OR SPECIFICATION OF OTHERS;The mark consists of the word dot within a rectangle with rounded corners.;PHARMACEUTICAL PREPARATIONS DISPENSED BY PRESCRIPTION ONLY, NAMELY, TRANSDERMAL ADHESIVE MATRIX PATCHES INTO WHICH A WIDE VARIETY OF BIOLOGICALLY ACTIVE AGENTS ARE PLACED FOR THE SYSTEMIC TREATMENT OF ALLERGIC, CARDIO-VASCULAR, INFECTIOUS, NEUROLOGICAL, INFLAMMATORY, IMMUNOLOGICAL, METABOLIC, VIRAL, MICROBIAL, OSTEOPATHIC, DIETARY, RESPIRATORY, PSYCHIATRIC, HORMONAL, DENTAL, DERMAL, MUSCULAR, AND EXCRETORY DISEASES, CONDITIONS, DEFICIENCIES AND DISORDERS;Color is not claimed as a feature of the mark.;

DOT

MANUFACTURE OF TRANSDERMAL PATCHES FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS TO ORDER AND/OR SPECIFICATION OF OTHERS;PHARMACEUTICAL PREPARATIONS DISPENSED BY PRESCRIPTION ONLY, NAMELY TRANSDERMAL ADHESIVE MATRIX PATCHES INTO WHICH A WIDE VARIETY OF BIOLOGICALLY ACTIVE AGENTS ARE PLACED FOR THE SYSTEMIC TREATMENT OF ALLERGIC, CARDIO-VASCULAR, INFECTIOUS, NEUROLOGICAL, INFLAMMATORY, IMMUNOLOGICAL, METABOLIC, VIRAL, MICROBIAL, OSTEOPATHIC, DIETARY, RESPIRATORY, PSYCHIATRIC, HORMONAL, DENTAL, DERMAL, MUSCULAR, AND EXCRETORY DISEASES, CONDITIONS, DEFICIENCIES AND DISORDERS;

DOT 7

Pharmaceutical preparations, namely therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of hormonal or steroidal active agents;DOT SEVEN;

DOT 7

Pharmaceutical preparations, namely, therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of hormonal or steroidal active agents;DOT SEVEN;

DOT 7

Pharmaceutical preparations, namely therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of hormonal or steroidal active agents;

DOT MATRIX

manufacture of therapeutic preparations in the form of a bandage or patch to be affixed to skin for delivery of a biologically active agent, to order and/or specification of others;transdermal delivery systems into which a wide variety of biologically active agents are placed for the treatment of allergic, cardio-vascular, infectious, neurological, inflammatory, immunological, metabolic, viral, microbial, osteopathic, dietary, respiratory, psychiatric, hormonal, dental, dermal, muscular and excretory diseases, conditions, deficiencies and disorders;

DOT MATRIX

transdermal delivery patches into which a wide variety of biologically active agents are placed for the treatment of allergic, cardio-vascular, infectious, neurological, inflammatory, immunological, metabolic, viral, microbial, osteopathic, dietary, respiratory, psychiatric, hormonal, dental, dermal, muscular and excretory diseases, conditions, deficiencies and disorders;

DOT MATRIX

Printed instructional and educational materials featuring information regarding transdermal drug delivery systems in the form of a bandage or patch and manufacture of same;

DOT MATRIX

Transdermal delivery patches into which a wide variety of biologically active agents are placed for the treatment of allergic, cardio-vascular, infectious, neurological, inflammatory, immunological, metabolic, viral, microbial, osteopathic, dietary, respiratory, psychiatric, hormonal, dental, dermal, muscular and excretory diseases, conditions, deficiencies and disorders;

DOT MATRIX

Transdermal delivery patches into which a wide variety of biologically active agents are placed for the treatment of allergic, cardio-vascular, infectious, neurological, inflammatory, immunological, metabolic, viral, microbial, osteopathic, dietary, respiratory, psychiatric, hormonal, dental, dermal, muscular and excretory diseases, conditions, deficiencies and disorders;

DOT SEVEN

Pharmaceutical preparations for hormonal therapy containing at least one steroidal or hormonal active agent;

DOT SEVEN

Pharmaceutical preparations for hormonal therapy containing at least one steroidal or hormonal active agent;DOT 7;

DOTINI

Pharmaceutical preparations for use in the treatment of gynecological disorders and conditions, namely, gynecological disorders and conditions affecting nervousness, depression, mood, anxiety, and cognitive function, perspiration, headache, palpitation, sleep, and bone and joint pain; pharmaceutical preparations for use in the treatment of sexual dysfunction; pharmaceutical preparations for use in contraception; pharmaceutical preparations and substances for the treatment of hormonal imbalances, disorders, and deficiencies; pharmaceutical preparations for use in the treatment of neurological diseases and disorders, psychiatric diseases and disorders, psychological diseases and disorders, cognitive impairment disorders, sleep disorders, panic disorders and anxiety disorders; pharmaceutical preparations and substances for use in the treatment, alleviation and prevention of pre- and post- menopausal symptoms and osteoporosis, as well as female disorders, ailments and conditions including hot flashes, night awakenings, night sweats, mood changes;

DOTLET

Pharmaceutical preparations for use in the treatment of gynecological disorders and conditions, namely, gynecological disorders and conditions affecting nervousness, depression, mood, anxiety, and cognitive function, perspiration, headache, palpitation, sleep, and bone and joint pain; pharmaceutical preparations for use in the treatment of sexual dysfunction; pharmaceutical preparations for use in contraception; pharmaceutical preparations and substances for the treatment of hormonal imbalances, disorders, and deficiencies; pharmaceutical preparations for use in the treatment of neurological diseases and disorders, psychiatric diseases and disorders, psychological diseases and disorders, cognitive impairment disorders, sleep disorders, panic disorders and anxiety disorders; pharmaceutical preparations and substances for use in the treatment, alleviation and prevention of pre- and post- menopausal symptoms and osteoporosis, as well as female disorders, ailments and conditions including hot flashes, night awakenings, night sweats, mood changes;DOT LET;

E-DOT

Pharmaceutical preparations, namely therapeutic systems in the form of a bandage or patch to be attached to skin or mucosal membranes for treatment of steroidal or hormonal deficiencies and imbalances;

ESTRADOT

pharmaceutical preparations, namely, therapeutic systems in the form of a bandage or patch to be attached to skin or mucosal membranes for delivery of a hormonal or steroidal active agent;

ESTRADOT

Pharmaceutical preparations, namely, therapeutic systems in the form of a bandage or patch to be attached to skin or mucosal membranes for delivery of a hormonal or steroidal active agent;

ESTRADOT

Pharmaceutical preparations, namely, therapeutic systems in the form of a bandage or patch to be attached to skin or mucosal membranes for delivery of a hormonal or steroidal active agent;

ESTRADOT

Pharmaceutical preparations, namely, therapeutic systems in the form of a bandage or patch to be attached to skin or mucosal membranes for delivery of a hormonal or steroidal active agent;

ESTRADOT

Pharmaceutical preparations, namely, therapeutic systems in the form of a bandage or patch to be attached to skin or mucosal membranes for treatment of steroidal or hormonal deficiencies and imbalances;

ETYSA

Pharmaceutical preparations, namely, contraceptives in the form of a transdermal patch;

FEMADERM

TRANSDERMALLY - DELIVERED HORMONAL THERAPY;

FEMDOT

Pharmaceutical preparations, namely, therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of hormonal or steroidal agents;FEM DOT;

FEMDOT

Pharmaceutical preparations, namely therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of hormonal or steroidal agents.;

FENTADOT

Pharmaceutical preparations, namely, therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of analgesic, sedative and narcotic agents;

FENTADOT

Pharmaceutical preparations, namely therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of analgesic, sedative and narcotic agents;

FENTAPATCH

Pharmaceutical preparations, namely, therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of analgesic, sedative and narcotic agents;

FENTAPATCH

Pharmaceutical preparations, namely therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of analgesic, sedative and narcotic agents;FENTA PATCH;

INIVE

pharmaceutical preparations, namely, contraceptives in the form of a transdermal patch;

INIVE

Pharmaceutical preparations, namely, contraceptives in the form of a transdermal patch;

MECIFEN

Pharmaceutical preparations in the form of a bandage and patch for use in the treatment of attention deficit disorders and hyperactivity;

MENODERM

TRANSDERMALLY - DELIVERED HORMONAL THERAPY;

MENOREST

pharmaceuticals for transdermally-delivered hormonal therapy;

MENOVEN

TRANSDERMALLY - DELIVERED HORMONAL THERAPY;

METADOT

Pharmaceutical preparations, namely therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of analgesic, sedative and narcotic agents;META DOT;

METADOT

Pharmaceutical preparations in the form of transdermal or transmucosal drug delivery bandages or patches containing analgesic, sedative and narcotic agents;

METADOT

Pharmaceutical preparations, namely therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of analgesic, sedative and narcotic agents;

METHYDERM

Transdermal and transmucosal drug delivery patches for use in the treatment of attention deficit disorder and attention deficit hyperactivity disorder;

METHYPATCH

Transdermal and transmucosal drug delivery patches for use in the treatment of attention deficit disorder and attention deficit hyperactivity disorder;

MINI-DOT

Pharmaceutical preparations, namely, therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of active agents for the treatment of hormonal conditions, imbalances and deficiencies;

MINI-DOT

Pharmaceutical preparations, namely therapeutic systems in the form of a bandage or patch for transdermal or transmucosal delivery of hormonal or steroidal active agents;

MINIDOT

Pharmaceutical preparations for the treatment of hormonal imbalances and deficiencies, pre- and post menopausal symptoms and osteoporosis as well as women's hormonal or reproductive disorders, ailments and conditions;MINI DOT;

MINIVELLE

Pharmaceutical preparations for use in the treatment [ of gynecological disorders and conditions, namely, gynecological disorders and conditions affecting nervousness, depression, mood, anxiety, and cognitive function, perspiration, headache, palpitation, sleep, and bone and joint pain; pharmaceutical preparations for use in the treatment of sexual dysfunction; pharmaceutical preparations for use in contraception; pharmaceutical preparations and substances for the treatment of hormonal imbalances, disorders, and deficiencies; pharmaceutical preparations for use in the treatment of neurological diseases and disorders, psychiatric diseases and disorders, psychological diseases and disorders, cognitive impairment disorders, sleep disorders, panic disorders and anxiety disorders; pharmaceutical preparations and substances for use in the treatment, ] alleviation and prevention of [ pre- and ] post- menopausal symptoms and osteoporosis, [ as well as female disorders, ailments and conditions ] including hot flashes * and* [, night awakenings, ] night sweats [, mood changes ];

MINIVELLE

The mark consists of a starburst design in which a series of overlapping squares forms the center of the design and geometric shapes form three successively larger circles surrounding the center and the wording MINIVELLE.;Pharmaceutical preparations for use in the treatment, alleviation and prevention of moderate to severe vasomotor symptoms associated with menopause and women's hormonal disorders;Color is not claimed as a feature of the mark.;